[Federal Register Volume 70, Number 215 (Tuesday, November 8, 2005)]
[Notices]
[Pages 67709-67713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-22192]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services


Privacy Act of 1974; Report of a New System of Records

AGENCY: Department of Health and Human Services (HHS) Centers for 
Medicare & Medicaid Services (CMS).

ACTION: Notice of a New System of Records (SOR).

-----------------------------------------------------------------------

SUMMARY: In accordance with the requirements of the Privacy Act of 
1974, we are proposing to establish a new

[[Page 67710]]

SOR titled, ``Medicare Prescription Drug Plan Finder (MPDPF) System, 
HHS/CMS/CBC, System No. 09-70-0564.'' Under the provisions of Section 
101 of the Medicare Prescription Drug, Improvement, and Modernization 
Act of 2003 (MMA) (Pub. L. 108-173), CMS has provided the participants 
of eligibility transactions a query and response solution in a single 
data center using a three-tier architecture. Enterprise Business 
Services (EBS), the user interface, will have the responsibility of 
receiving identifying information on Medicare beneficiaries for 
processing eligibility requests and enrollment assistance with the 
Medicare Prescription Drug Benefit Program. These inbound messages will 
be sent to EBS for processing of the eligibility request and for 
securing the information from the CMS Community Based Organization/
Customer Service Representative (CBO/CSR) Data Store, and for sending 
an available plan option response back via the internet. EBS will 
capture the identifying information and enrollment selection, and 
transmit it to the selected Medicare Prescription Drug Plan (PDP) or 
Medicare Advantage Prescription Drug Plan (MAPD). This initiative will 
streamline and facilitate drug benefit eligibility determination and 
the enrollment process.
    The primary purpose of this system is to provide a Web accessible 
inquiry system that will provide a mechanism to support an individual 
beneficiary's efforts in performing drug benefit eligibility queries 
and to enroll them into selected plans. Information in this system will 
also be used to: (1) Support regulatory and policy functions performed 
within the Agency or by a contractor or consultant; (2) assist PDPs and 
MAPDs directly or through the Enterprise Business Services; (3) support 
constituent requests made to a Congressional representative; and (4) 
support litigation involving the Agency related to this system. We have 
provided background information about the proposed system in the 
``Supplementary Information'' section below. Although the Privacy Act 
requires only that the Aroutine use'' portion of the system be 
published for comment, CMS invites comments on all portions of this 
notice. See EFFECTIVE DATES section for comment period.

EFFECTIVE DATES: CMS filed a new system report with the Chair of the 
House Committee on Government Reform and Oversight, the Chair of the 
Senate Committee on Governmental Affairs, and the Administrator, Office 
of Information and Regulatory Affairs, Office of Management and Budget 
(OMB) on November 1, 2005. To ensure that all parties have adequate 
time in which to comment, the new SOR, including routine uses, will 
become effective 40 days from the publication of the notice, or from 
the date it was submitted to OMB and the Congress, whichever is later, 
unless CMS receives comments that require alterations to this notice.

ADDRESSES: The public should address comments to: CMS Privacy Officer, 
Division of Privacy Compliance Data Development, CMS, Mail Stop N2-04-
27, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. Comments 
received will be available for review at this location, by appointment, 
during regular business hours, Monday through Friday from 9 a.m.-3 
p.m., eastern daylight time.

FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Division of Website 
Project Management, Beneficiary Information Services Group, Center for 
Beneficiary Choices, CMS, Mail Stop S1-01-26, 7500 Security Boulevard, 
Baltimore, Maryland, 21244-1850. His telephone number is 410-786-1442, 
or e-mail at <a href="/cdn-cgi/l/email-protection#33675b5c5e52401d7746575f564a73505e401d5b5b401d545c45"><span class="__cf_email__" data-cfemail="5c083433313d2f721829383039251c3f312f7234342f723b332a">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The public version of the toll will use 
knowledge based authentication (KBA), to provide the end user access to 
personalized information about their drug benefit eligibility and 
enrollment. KBA allows a user to access the system based on what they 
know without the need for a user id/password. To successfully 
authenticate, the user will need to provide the following information: 
Health Insurance Claim Number (HICN), Date of Birth, Last Name, Type of 
Enrollment, Effective date of enrollment, and Zip Code. This 
information will then be validated in the CMS Data Center. All data 
elements must match to successfully authenticate the user. If the 
authentication fails, the user will be taken directly to the default 
route and asked to respond to a series of questions in lieu of 
authentication. They will not be provided with ``retry'' options. If 
successfully authenticated, Part D and Part C information will be 
retrieved from the data center and passed to MPDPF.
    CMS has planned to provide the participants of eligibility 
transactions a query and response solution in a single data center 
using a three-tier architecture. EBS, the user interface, will have the 
responsibility of receiving identifying information on Medicare 
beneficiaries for processing eligibility requests and enrollment 
assistance with the Medicare Prescription Drug Benefit Program. These 
inbound messages will be sent to EBS for processing of the eligibility 
request and for securing the information from the CMS CBO/CSR Data 
Store, and for sending a response back via the internet.
    The drug benefit itself is very complex. The user must self-
identify him/herself into one of 4 categories in order to get the 
options applicable in his/her circumstances (full dual subsidy 
eligible; full subsidy eligible; partial subsidy eligible; no subsidy 
eligible). CMS knows from prior education and consumer research efforts 
that it is extremely difficult for persons with Medicare to understand 
the nuances of these options and to accurately categorize them. This 
presents a challenge for both the direct beneficiary user and those 
assisting the beneficiary (CSRs and CBOs). However, CMS data systems 
contain information that can easily provide the user's categorization 
and then enable the drug benefit tool to accurately present only those 
options that are applicable to his/her unique circumstances. This is 
the primary driver for the development of the eligibility query.
    A secondary, but also essential, driver is to provide an efficient 
means for users to explore their drug benefit choices. We need to 
ensure that we provide tools that can encourage the maximum number of 
Medicare beneficiaries to use self-service options given the volume of 
inquiries we are projecting and the extraordinary costs for servicing 
those calls. To meet the varying needs of different end-users, two 
different versions of the MPDPF will be developed: one tool will be 
used for the Public (including CBOs, and beneficiaries) and the other 
tool will be dedicated to CSR staffing the call centers that service 1-
800-Medicare.

I. Description of the Proposed System of Records

A. Statutory and Regulatory Basis for the System

    Authority for this system is given under the provisions of Section 
101 of the Medicare Prescription Drug, Improvement, and Modernization 
Act of 2003 (MMA) (Public Law 108-173). This new prescription drug 
benefit program was enacted into law on December 8, 2003, amended Title 
XVIII of the Social Security Act (the Act), and codified at Title 42 
Code of Federal Regulations (CFR) Parts 403, 411, 417 and 423 by 
establishing a new Medicare ``Part D'' Prescription Drug Benefit 
program. Part D of Title XVIII of the Act, as amended by the MMA, and 
its implementing regulations at 42 CFR Parts 403, 411, 417 and 423.

[[Page 67711]]

B. Collection and Maintenance of Data in the System

    Information collected for this system will include but is not 
limited to, individuals who voluntarily access and who successfully 
validate information required by the Web-based Application Systems 
maintained by CMS. Information collected for this system will include, 
but is not limited to, last name, gender, HICN, telephone number, 
geographic location, type of enrollment (Medicare Part A or Part B), 
and effective date of enrollment in Part A and Part B.

II. Agency Policies, Procedures, and Restrictions on the Routine Use

A. Agency Policies, Procedures, and Restrictions on the Routine Use

    The Privacy Act permits us to disclose information without an 
individual's consent if the information is to be used for a purpose 
that is compatible with the purpose(s) for which the information was 
collected. Any such disclosure of data is known as a ``routine use.'' 
The government will only release MPDPF information that can be 
associated with an individual as provided for under ``Section III. 
Proposed Routine Use Disclosures of Data in the System.'' Both 
identifiable and non-identifiable data may be disclosed under a routine 
use.
    We will only collect the minimum personal data necessary to achieve 
the purpose of MPDPF. CMS has the following policies and procedures 
concerning disclosures of information that will be maintained in the 
system. Disclosure of information from the system will be approved only 
to the extent necessary to accomplish the purpose of the disclosure and 
only after CMS:
    1. Determines that the use or disclosure is consistent with the 
reason that the data is being collected, e.g., to provide a Web 
accessible inquiry system that will provide a mechanism to support an 
individual beneficiary's efforts in performing drug benefit eligibility 
queries and to enroll them into selected plans.
    2. Determines that:
    a. The purpose for which the disclosure is to be made can only be 
accomplished if the record is provided in individually identifiable 
form;
    b. The purpose for which the disclosure is to be made is of 
sufficient importance to warrant the effect and/or risk on the privacy 
of the individual that additional exposure of the record might bring; 
and
    c. There is a strong probability that the proposed use of the data 
would in fact accomplish the stated purpose(s).
    3. Requires the information recipient to:
    a. Establish administrative, technical, and physical safeguards to 
prevent unauthorized use of disclosure of the record;
    b. Remove or destroy at the earliest time all patient-identifiable 
information; and
    c. Agree to not use or disclose the information for any purpose 
other than the stated purpose under which the information was 
disclosed.
    4. Determines that the data are valid and reliable.

III. Proposed Routine Use Disclosures of Data in the System

    A. The Privacy Act allows us to disclose information without an 
individual's consent if the information is to be used for a purpose 
that is compatible with the purpose(s) for which the information was 
collected. Any such compatible use of data is known as a ``routine 
use.'' The proposed routine uses in this system meet the compatibility 
requirement of the Privacy Act. We are proposing to establish the 
following routine use disclosures of information maintained in the 
system.
    1. To Agency contractors, or consultants who have been contracted 
by the Agency to assist in accomplishment of a CMS function relating to 
the purposes for this system and who need to have access to the records 
in order to assist CMS.
    We contemplate disclosing information under this routine use only 
in situations in which CMS may enter into a contractual or similar 
agreement with a third party to assist in accomplishing CMS functions 
relating to purposes for this system.
    CMS occasionally contracts out certain of its functions when this 
would contribute to effective and efficient operations. CMS must be 
able to give a contractor whatever information is necessary for the 
contractor to fulfill its duties. In these situations, safeguards are 
provided in the contract prohibiting the contractor from using or 
disclosing the information for any purpose other than that described in 
the contract and to return or destroy all information at the completion 
of the contract.
    2. To Medicare Prescription Drug Plans (PDP) and Medicare Advantage 
Prescription Drug Plans (MAPD) directly or through the Enterprise 
Business Services, a CMS intermediary for the administration of Title 
XVIII of the Act.
    PDPs and MAPDs require MPDPF information in order to establish the 
validity of evidence or to verify the accuracy of information presented 
by the individual, as it concerns the individual's entitlement to Part 
D benefits under the Medicare Prescription Drug Benefit Program.
    3. To a Member of Congress or to a Congressional staff member in 
response to an inquiry of the Congressional office made at the written 
request of the constituent about whom the record is maintained.
    Individuals sometimes request the help of a Member of Congress in 
resolving some issue relating to a matter before CMS. The Member of 
Congress then writes CMS, and CMS must be able to give sufficient 
information to be responsive to the inquiry.
    4. To the Department of Justice (DOJ), court or adjudicatory body 
when
    a. The Agency or any component thereof; or
    b. Any employee of the Agency in his or her official capacity; or
    c. Any employee of the Agency in his or her individual capacity 
where the DOJ has agreed to represent the employee; or
    d. The United States Government;

is a party to litigation or has an interest in such litigation, and by 
careful review, CMS determines that the records are both relevant and 
necessary to the litigation. Whenever CMS is involved in litigation, or 
occasionally when another party is involved in litigation and CMS's 
policies or operations could be affected by the outcome of the 
litigation, CMS would be able to disclose information to the DOJ, court 
or adjudicatory body involved. A determination would be made in each 
instance that, under the circumstances involved, the purposes served by 
the use of the information in the particular litigation is compatible 
with a purpose for which CMS collects the information.
    B. Additional Provisions Affecting Routine Use Disclosures. This 
system contains Protected Health Information (PHI) as defined by HHS 
regulation ``Standards for Privacy of Individually Identifiable Health 
Information'' (45 CFR Parts 160 and 164, Subparts A and E, 65 FR 82462 
(12-28-00)). Disclosures of PHI authorized by these routine uses may 
only be made if, and as, permitted or required by the ``Standards for 
Privacy of Individually Identifiable Health Information.''
    In addition, our policy will be to prohibit release even of not 
directly identifiable information, except pursuant to one of the 
routine uses or if required by law, if we determine there is a 
possibility that an individual can be identified through implicit 
deduction based on small cell sizes (instances where the patient 
population is so small

[[Page 67712]]

that individuals who are familiar with the enrollees could, because of 
the small size, use this information to deduce the identity of the 
beneficiary).

IV. Safeguards

    CMS has safeguards in place for authorized users and monitors such 
users to ensure against excessive or unauthorized use. Personnel having 
access to the system have been trained in the Privacy Act and 
information security requirements. Employees who maintain records in 
this system are instructed not to release data until the intended 
recipient agrees to implement appropriate management, operational and 
technical safeguards sufficient to protect the confidentiality, 
integrity and availability of the information and information systems 
and to prevent unauthorized access.
    This system will conform to all applicable Federal laws and 
regulations and Federal, HHS, and CMS policies and standards as they 
relate to information security and data privacy. These laws and 
regulations include but are not limited to: The Privacy Act of 1974; 
the Federal Information Security Management Act of 2002; the Computer 
Fraud and Abuse Act of 1986; the Health Insurance Portability and 
Accountability Act of 1996; the E-Government Act of 2002, the Clinger-
Cohen Act of 1996; the Medicare Modernization Act of 2003, and the 
corresponding implementing regulations. OMB Circular A-130, Management 
of Federal Resources, Appendix III, Security of Federal Automated 
Information Resources also applies. Federal, HHS, and CMS policies and 
standards include but are not limited to: All pertinent National 
Institute of Standards and Technology publications; HHS Information 
Systems Program Handbook and the CMS Information Security Handbook.

V. Effects of the Proposed System of Records on Individual Rights

    CMS proposes to establish this system in accordance with the 
principles and requirements of the Privacy Act and will collect, use, 
and disseminate information only as prescribed therein. Data in this 
system will be subject to the authorized releases in accordance with 
the routine uses identified in this system of records.
    CMS will take precautionary measures to minimize the risks of 
unauthorized access to the records and the potential harm to individual 
privacy or other personal or property rights of patients whose data are 
maintained in the system. CMS will collect only that information 
necessary to perform the system's functions. In addition, CMS will make 
disclosure from the proposed system only with consent of the subject 
individual, or his/her legal representative, or in accordance with an 
applicable exception provision of the Privacy Act. CMS, therefore, does 
not anticipate an unfavorable effect on individual privacy as a result 
of the disclosure of information relating to individuals.

    Dated: October 27, 2005.
Charlene Frizzera,
Deputy Chief Operating Officer, Centers for Medicare & Medicaid 
Services.
09-70-0564

SYSTEM NAME:
    ``Medicare Prescription Drug Plan Finder (MPDPF) System, HHS/CMS/
CBC''

SECURITY CLASSIFICATION:
    Level 3 Privacy Act Sensitive

SYSTEM LOCATION:
    Centers for Medicare & Medicaid Services (CMS) Data Center, 7500 
Security Boulevard, North Building, First Floor, Baltimore, Maryland 
21244-1850, and at various contractor locations.

CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM:
    Information collected for this system will include but is not 
limited to, individuals who voluntarily access and who successfully 
validate information required by the Web-based Application Systems 
maintained by CMS.

CATEGORIES OF RECORDS IN THE SYSTEM:
    Information collected for this system will include, but is not 
limited to, last name, gender, Health Insurance Claim Number (HICN), 
telephone number, geographic location, type of enrollment (Medicare 
Part A or Part B), and effective date of enrollment in Part A and Part 
B.

AUTHORITY FOR MAINTENANCE OF THE SYSTEM:
    Authority for this system is given under the provisions of Section 
101 of the Medicare Prescription Drug, Improvement, and Modernization 
Act of 2003 (MMA) (Public Law 108-173). This new prescription drug 
benefit program was enacted into law on December 8, 2003, amended Title 
XVIII of the Social Security Act (the Act), and codified at Title 42 
Code of Federal Regulations (CFR) parts 403, 411, 417 and 423 by 
establishing a new Medicare ``Part D'' Prescription Drug Benefit 
program. Part D of Title XVIII of the Act, as amended by the MMA, and 
its implementing regulations at 42 CFR Parts 403, 411, 417 and 423.

PURPOSE(S) OF THE SYSTEM:
    The primary purpose of this system is to provide a Web accessible 
inquiry system that will provide a mechanism to support an individual 
beneficiary's efforts in performing drug benefit eligibility queries 
and to enroll them into selected plans. Information in this system will 
also be used to: (1) Support regulatory and policy functions performed 
within the Agency or by a contractor or consultant; (2) assist PDPs and 
MAPDs directly or through the Enterprise Business Services; (3) support 
constituent requests made to a Congressional representative; and (4) 
support litigation involving the Agency related to this system.

ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING CATEGORIES 
OR USERS AND THE PURPOSES OF SUCH USES:
    A. The Privacy Act allows us to disclose information without an 
individual's consent if the information is to be used for a purpose 
that is compatible with the purpose(s) for which the information was 
collected. Any such compatible use of data is known as a ``routine 
use.'' The proposed routine uses in this system meet the compatibility 
requirement of the Privacy Act. We are proposing to establish the 
following routine use disclosures of information maintained in the 
system:
    1. To Agency contractors, or consultants who have been contracted 
by the Agency to assist in accomplishment of a CMS function relating to 
the purposes for this system and who need to have access to the records 
in order to assist CMS.
    2. To Medicare Prescription Drug Plans (PDP) and Medicare Advantage 
Prescription Drug Plans (MAPD) directly or through the Enterprise 
Business Services, a CMS intermediary for the administration of Title 
XVIII of the Act.
    3. To a Member of Congress or to a congressional staff member in 
response to an inquiry of the congressional office made at the written 
request of the constituent about whom the record is maintained.
    4. To the Department of Justice (DOJ), court or adjudicatory body 
when
    a. The Agency or any component thereof; or
    b. any employee of the Agency in his or her official capacity; or
    c. any employee of the Agency in his or her individual capacity 
where the DOJ has agreed to represent the employee; or
    d. The United States Government;
    Is a party to litigation or has an interest in such litigation, and 
by careful review, CMS determines that the

[[Page 67713]]

records are both relevant and necessary to the litigation.
    B. Additional Provisions Affecting Routine Use Disclosures. This 
system contains Protected Health Information (PHI) as defined by HHS 
regulation ``Standards for Privacy of Individually Identifiable Health 
Information'' (45 CFR Parts 160 and 164, Subparts A and E , 65 Fed. 
Reg. 82462 (12-28-00)). Disclosures of PHI authorized by these routine 
uses may only be made if, and as, permitted or required by the 
``Standards for Privacy of Individually Identifiable Health 
Information.''
    In addition, our policy will be to prohibit release even of not 
directly identifiable information, except pursuant to one of the 
routine uses or if required by law, if we determine there is a 
possibility that an individual can be identified through implicit 
deduction based on small cell sizes (instances where the patient 
population is so small that individuals who are familiar with the 
enrollees could, because of the small size, use this information to 
deduce the identity of the beneficiary).

POLICIES AND PRACTICES FOR STORING, RETRIEVING, ACCESSING, RETAINING, 
AND DISPOSING OF RECORDS IN THE SYSTEM:
STORAGE:
    Computer diskette and on magnetic storage media.

RETRIEVABILITY:
    Information can be retrieved by the individual identifiable 
information of the beneficiary.

SAFEGUARDS:
    CMS has safeguards in place for authorized users and monitors such 
users to ensure against excessive or unauthorized use. Personnel having 
access to the system have been trained in the Privacy Act and 
information security requirements. Employees who maintain records in 
this system are instructed not to release data until the intended 
recipient agrees to implement appropriate management, operational and 
technical safeguards sufficient to protect the confidentiality, 
integrity and availability of the information and information systems 
and to prevent unauthorized access.
    This system will conform to all applicable Federal laws and 
regulations and Federal, HHS, and CMS policies and standards as they 
relate to information security and data privacy. These laws and 
regulations include but are not limited to: the Privacy Act of 1974; 
the Federal Information Security Management Act of 2002; the Computer 
Fraud and Abuse Act of 1986; the Health Insurance Portability and 
Accountability Act of 1996; the E-Government Act of 2002, the Clinger-
Cohen Act of 1996; the Medicare Modernization Act of 2003, and the 
corresponding implementing regulations. OMB Circular A-130, Management 
of Federal Resources, Appendix III, Security of Federal Automated 
Information Resources also applies. Federal, HHS, and CMS policies and 
standards include but are not limited to: all pertinent National 
Institute of Standards and Technology publications; HHS Information 
Systems Program Handbook and the CMS Information Security Handbook.

RETENTION AND DISPOSAL:
    Records are maintained in a secure storage area with identifiers. 
Disposal occurs 6 years and 3 months from the time the individual 
accesses the MPDPF.

SYSTEM MANAGER AND ADDRESS:
    Director, Beneficiary Information Services Group, Center for 
Beneficiary Choices, CMS, Mail Stop S1-01-26, 7500 Security Boulevard, 
Baltimore, Maryland, 21244-1850.

NOTIFICATION PROCEDURE:
    For purpose of access, the subject individual should write to the 
system manager who will require the system name, HICN, and for 
verification purposes, the subject individual's name (woman's maiden 
name, if applicable).

RECORD ACCESS PROCEDURE:
    For purpose of access, use the same procedures outlined in 
Notification Procedures above. Requestors should also reasonably 
specify the record contents being sought. (These procedures are in 
accordance with Department regulation 45 CFR 5b.5 (a)(2).)

CONTESTING RECORD PROCEDURES:
    The subject individual should contact the system manager named 
above, and reasonably identify the record and specify the information 
to be contested. State the corrective action sought and the reasons for 
the correction with supporting justification. (These procedures are in 
accordance with Department regulation 45 CFR 5b.7.)

RECORD SOURCE CATEGORIES:
    Sources of information contained in this records system include 
data collected from the initial voluntary inquiry made by or on behalf 
of the individual and validated through the Medicare Beneficiary 
Database.

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT:
    None.

[FR Doc. 05-22192 Filed 11-7-05; 8:45 am]
BILLING CODE 4120-03-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>